APA (7th ed.) Citation

Cecchi, F., Rex, K., Schmidt, J., Vocke, C. D., Lee, Y. H., Burkett, S., . . . Bottaro, D. P. (2023). Rilotumumab Resistance Acquired by Intracrine Hepatocyte Growth Factor Signaling. Cancers, 15(2), 460. https://doi.org/10.3390/cancers15020460

Chicago Style (17th ed.) Citation

Cecchi, Fabiola, et al. "Rilotumumab Resistance Acquired by Intracrine Hepatocyte Growth Factor Signaling." Cancers 15, no. 2 (2023): 460. https://doi.org/10.3390/cancers15020460.

MLA (9th ed.) Citation

Cecchi, Fabiola, et al. "Rilotumumab Resistance Acquired by Intracrine Hepatocyte Growth Factor Signaling." Cancers, vol. 15, no. 2, 2023, p. 460, https://doi.org/10.3390/cancers15020460.